391 related articles for article (PubMed ID: 26489798)
1. Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.
Wang Y; Schmitt K; Guo K; Santiago ML; Stephens EB
J Gen Virol; 2016 Jan; 97(1):1-17. PubMed ID: 26489798
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1.
McDonnell MM; Crawford KHD; Dingens AS; Bloom JD; Emerman M
mBio; 2020 Apr; 11(2):. PubMed ID: 32345636
[TBL] [Abstract][Full Text] [Related]
3. Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.
Mitra M; Singer D; Mano Y; Hritz J; Nam G; Gorelick RJ; Byeon IJ; Gronenborn AM; Iwatani Y; Levin JG
Retrovirology; 2015 Jan; 12():3. PubMed ID: 25614027
[TBL] [Abstract][Full Text] [Related]
4. Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.
Stavrou S; Crawford D; Blouch K; Browne EP; Kohli RM; Ross SR
PLoS Pathog; 2014 May; 10(5):e1004145. PubMed ID: 24851906
[TBL] [Abstract][Full Text] [Related]
5. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.
Ooms M; Krikoni A; Kress AK; Simon V; Münk C
J Virol; 2012 Jun; 86(11):6097-108. PubMed ID: 22457529
[TBL] [Abstract][Full Text] [Related]
6. Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms.
McDonnell MM; Karvonen SC; Gaba A; Flath B; Chelico L; Emerman M
PLoS Pathog; 2021 Jun; 17(6):e1009523. PubMed ID: 34170969
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
8. Human cytidine deaminase APOBEC3H restricts HIV-1 replication.
Dang Y; Siew LM; Wang X; Han Y; Lampen R; Zheng YH
J Biol Chem; 2008 Apr; 283(17):11606-14. PubMed ID: 18299330
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1.
Jaguva Vasudevan AA; Hofmann H; Willbold D; Häussinger D; Koenig BW; Münk C
J Mol Biol; 2017 Apr; 429(8):1171-1191. PubMed ID: 28315663
[TBL] [Abstract][Full Text] [Related]
10. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
11. APOBEC3A damages the cellular genome during DNA replication.
Green AM; Landry S; Budagyan K; Avgousti DC; Shalhout S; Bhagwat AS; Weitzman MD
Cell Cycle; 2016; 15(7):998-1008. PubMed ID: 26918916
[TBL] [Abstract][Full Text] [Related]
12. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.
Goila-Gaur R; Khan MA; Miyagi E; Kao S; Strebel K
Retrovirology; 2007 Aug; 4():61. PubMed ID: 17727729
[TBL] [Abstract][Full Text] [Related]
13. Natural APOBEC3C variants can elicit differential HIV-1 restriction activity.
Anderson BD; Ikeda T; Moghadasi SA; Martin AS; Brown WL; Harris RS
Retrovirology; 2018 Dec; 15(1):78. PubMed ID: 30558640
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.
Bouzidi MS; Caval V; Suspène R; Hallez C; Pineau P; Wain-Hobson S; Vartanian JP
J Mol Biol; 2016 Aug; 428(17):3514-28. PubMed ID: 27289067
[TBL] [Abstract][Full Text] [Related]
15. Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2.
Meissner ME; Willkomm NA; Lucas J; Arndt WG; Aitken SF; Julik EJ; Baliga S; Mansky LM
J Mol Biol; 2022 Jan; 434(2):167355. PubMed ID: 34774569
[TBL] [Abstract][Full Text] [Related]
16. Deaminase-Dead Mouse APOBEC3 Is an
Stavrou S; Zhao W; Blouch K; Ross SR
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
[TBL] [Abstract][Full Text] [Related]
17. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
[TBL] [Abstract][Full Text] [Related]
18. [APOBEC3s: history of an antiviral and mutagenic protein family].
Verriez C; Marquet R; Paillart JC; Stupfler B
Virologie (Montrouge); 2020 Dec; 24(6):381-418. PubMed ID: 33441290
[TBL] [Abstract][Full Text] [Related]
19. Repair of APOBEC3G-Mutated Retroviral DNA
Salas-Briceno K; Ross SR
J Virol; 2021 Oct; 95(22):e0124421. PubMed ID: 34468176
[TBL] [Abstract][Full Text] [Related]
20. Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.
Henry M; Guétard D; Suspène R; Rusniok C; Wain-Hobson S; Vartanian JP
PLoS One; 2009; 4(1):e4277. PubMed ID: 19169351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
